Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $171.77 USD
Change Today -0.61 / -0.35%
Volume 40.2K
BCR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 10:22 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

cr bard inc (BCR) Snapshot

Open
$172.53
Previous Close
$172.38
Day High
$172.98
Day Low
$171.45
52 Week High
04/24/15 - $180.94
52 Week Low
06/18/14 - $135.80
Market Cap
12.8B
Average Volume 10 Days
402.4K
EPS TTM
$7.75
Shares Outstanding
74.2M
EX-Date
04/23/15
P/E TM
22.2x
Dividend
$0.88
Dividend Yield
0.51%
Current Stock Chart for CR BARD INC (BCR)

cr bard inc (BCR) Related Businessweek News

No Related Businessweek News Found

cr bard inc (BCR) Details

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products that include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as other products, such as irrigation, wound drainage, and original equipment manufacturers’ products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

13,900 Employees
Last Reported Date: 02/18/15
Founded in 1907

cr bard inc (BCR) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.1M
President, Chief Operating Officer and Direct...
Total Annual Compensation: $887.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $594.5K
Group President
Total Annual Compensation: $594.5K
Group President
Total Annual Compensation: $592.1K
Compensation as of Fiscal Year 2014.

cr bard inc (BCR) Key Developments

CR Bard Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 04:20 PM

CR Bard Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 04:20 PM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Christopher S. Holland, Chief Financial Officer and Senior Vice President.

C. R. Bard Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

C. R. Bard Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, net sales were $819,700,000 against $799,300,000 for the same period in the last year. Income from operations before income taxes was $184,600,000 against $183,600,000 for the same period in the last year. Net income was $139,800,000 or $1.82 per diluted share available to common shareholders against $148,400,000 or $1.86 per diluted share available to common shareholders for the same period in the last year. Adjusted earnings were $161.6 million or $2.10 per diluted share against $152.6 million or $1.91 per diluted share for the same period in the last year. For  the first quarter 2015, net income was $139.8 million and diluted earnings per share were $1.82, a decrease of 6 percent and  2 percent, respectively, as compared to  first quarter 2014  results.  Adjusting for  certain items  that affect comparability between periods first quarter 2015 net income was $142.4 million and diluted earnings per share,  after adjusting for certain items that affect  comparability between periods and excluding  amortization of intangible assets,  were $2.10, an increase  of 6% and 10% respectively, as compared to first quarter 2014 results.

CR Bard Inc. Declares Quarterly Dividend, Payable on May 8, 2015

The Board of Directors of C. R. Bard Inc. declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on May 8, 2015 to shareholders of record at the close of business on April 27, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $171.77 USD -0.61

BCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Edwards Lifesciences Corp $131.87 USD +0.05
Endo International PLC $85.55 USD +0.55
Mettler-Toledo International Inc $330.74 USD -0.10
Sigma-Aldrich Corp $139.06 USD -0.03
Terumo Corp ¥2,825 JPY -26.00
View Industry Companies
 

Industry Analysis

BCR

Industry Average

Valuation BCR Industry Range
Price/Earnings 47.0x
Price/Sales 3.8x
Price/Book 7.3x
Price/Cash Flow 44.9x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit www.crbard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.